Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:EVHNYSE:FCNYSE:JPOTCMKTS:PHILNASDAQ:RCM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEVHEvolent Health$11.79+0.5%$9.24$7.06▼$33.63$1.38B1.012.53 million shs1.47 million shsFCFranklin Covey$21.85-9.6%$22.55$18.94▼$44.46$287.03M0.8696,430 shs467,756 shsJPJupai$0.40$0.37▼$1.79N/AN/AN/AN/APHILPHI Group$0.00-50.0%$0.00$0.00▼$0.00N/A-0.3760.25 million shs121.40 million shsRCMR1 RCM$14.31$14.28$12.39▼$14.32$6.04B0.844.22 million shsN/AInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEVHEvolent Health0.00%+5.34%+43.90%+18.14%-40.27%FCFranklin Covey0.00%-6.67%-2.50%+5.71%-43.89%JPJupai0.00%0.00%0.00%0.00%0.00%PHILPHI Group0.00%0.00%-50.00%-50.00%-66.67%RCMR1 RCM0.00%0.00%0.00%0.00%+28.57%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationEVHEvolent Health1.733 of 5 stars3.53.00.00.01.80.00.0FCFranklin Covey3.6871 of 5 stars3.52.00.00.02.32.52.5JPJupaiN/AN/AN/AN/AN/AN/AN/AN/APHILPHI GroupN/AN/AN/AN/AN/AN/AN/AN/ARCMR1 RCM1.0749 of 5 stars1.10.00.03.60.03.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEVHEvolent Health 3.00Buy$17.7950.85% UpsideFCFranklin Covey 3.00Buy$35.0060.22% UpsideJPJupai 0.00N/AN/AN/APHILPHI Group 0.00N/AN/AN/ARCMR1 RCM 2.10Hold$15.035.02% UpsideCurrent Analyst Ratings BreakdownLatest RCM, EVH, FC, JP, and PHIL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/3/2025FCFranklin CoveyBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$35.006/20/2025EVHEvolent HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$13.005/13/2025EVHEvolent HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$15.00 ➝ $15.005/9/2025EVHEvolent HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$14.00 ➝ $15.004/28/2025EVHEvolent HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$13.00 ➝ $13.004/10/2025EVHEvolent HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $14.004/10/2025FCFranklin CoveyBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$35.00 ➝ $35.00(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEVHEvolent Health$2.55B0.54$1.52 per share7.77$8.70 per share1.36FCFranklin Covey$287.23M0.99$2.68 per share8.15$6.35 per share3.44JPJupai$4.76MN/AN/AN/A$3.66 per shareN/APHILPHI GroupN/AN/AN/AN/AN/AN/ARCMR1 RCM$2.25B2.68$0.69 per share20.89$6.66 per share2.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEVHEvolent Health-$61.62M-$1.23N/AN/AN/A-4.54%3.64%1.44%8/6/2025 (Estimated)FCFranklin Covey$23.40M$0.7927.6516.182.323.81%18.28%5.98%N/AJPJupai-$3.33MN/A0.00N/AN/AN/AN/AN/AN/APHILPHI Group-$8.19MN/A0.00∞N/AN/AN/A-7,490.60%N/ARCMR1 RCM$3.30M-$0.15N/A71.55N/A-2.48%-2.18%-1.10%N/ALatest RCM, EVH, FC, JP, and PHIL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/2/2025Q3 2025FCFranklin Covey-$0.08$0.18+$0.26-$0.11$67.49 million$67.12 million5/8/2025Q1 2025EVHEvolent Health$0.08$0.06-$0.02-$0.63$460.15 million$483.65 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEVHEvolent HealthN/AN/AN/AN/AN/AFCFranklin CoveyN/AN/AN/AN/AN/AJPJupaiN/AN/AN/AN/AN/APHILPHI GroupN/AN/AN/AN/AN/ARCMR1 RCMN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEVHEvolent Health0.690.980.98FCFranklin Covey0.030.900.87JPJupaiN/AN/AN/APHILPHI GroupN/AN/AN/ARCMR1 RCM0.761.791.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEVHEvolent HealthN/AFCFranklin Covey69.88%JPJupaiN/APHILPHI GroupN/ARCMR1 RCM61.10%Insider OwnershipCompanyInsider OwnershipEVHEvolent Health1.40%FCFranklin Covey15.50%JPJupai39.30%PHILPHI Group31.96%RCMR1 RCM36.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEVHEvolent Health4,500117.40 million115.76 millionOptionableFCFranklin Covey1,15012.99 million10.98 millionOptionableJPJupai580N/AN/AOptionablePHILPHI Group446.87 billion31.89 billionNot OptionableRCMR1 RCM30,000422.39 million266.95 millionOptionableRCM, EVH, FC, JP, and PHIL HeadlinesRecent News About These Companies8 RCM headlines to know from JuneJuly 3 at 5:56 PM | beckershospitalreview.comBR1 Appoints Dave Wojczynski as President to Lead Physician Revenue Cycle Management BusinessJune 18, 2025 | finance.yahoo.comFormer Revecore CEO joins R1 RCMJune 18, 2025 | beckershospitalreview.comB'Order the New Mountain special': How one private equity firm is bringing big exits back to healthcare VCJune 16, 2025 | businessinsider.comR1 RCM names two executivesJune 12, 2025 | beckershospitalreview.comBR1 Expands Finance and Corporate Development Teams with New AppointmentsJune 11, 2025 | finance.yahoo.comTech company widens South Bay buying binge with new property dealJune 2, 2025 | eastbaytimes.comE8 RCM headlines to know from MayJune 2, 2025 | beckershospitalreview.comBCybersecurity firm continues real estate growth, buys Sunnyvale building at a discountJune 2, 2025 | bizjournals.comFierce Healthcare Fundraising Tracker —Zeal Capital Partners collects $82M; R1 secures investment from Khosla VenturesJune 2, 2025 | fiercehealthcare.comFBig tech company widens South Bay buying binge with new property dealJune 2, 2025 | mercurynews.comMR1 RCM secures investment to boost AI effortsMay 28, 2025 | beckershospitalreview.comBR1 Announces Investment from Khosla Ventures as it Accelerates AI-Driven Healthcare TransformationMay 28, 2025 | finance.yahoo.com3 RCM companies combineMay 20, 2025 | beckershospitalreview.comBBlack Book Research: Robotic Process Automation Transforms Healthcare RCM: 2025 Survey Highlights From Black BookApril 25, 2025 | finanznachrichten.de9 Under-the-Radar AI Innovations Set to Transform Healthcare Revenue Cycle Management- Black Book ResearchApril 21, 2025 | finance.yahoo.comMeet the two twenty-somethings running Palantir's healthcare AI businessApril 3, 2025 | businessinsider.comHealthcare Revenue Cycle Management Market is Expected to Reach ~11–12% CAGR by 2027March 31, 2025 | pharmiweb.comPThe U.S. Revenue Cycle Management Market Surges to $272.78 Billion by 2030, Multi-Billion Opportunity Projected in the Coming Years – AriztonMarch 27, 2025 | theglobeandmail.comCould Palantir's R1 Deal Be the Catalyst for a Stock Surge?March 21, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseThese 3 Dividend Stocks Pay You to Stay Calm in SummerBy Chris Markoch | June 9, 2025View These 3 Dividend Stocks Pay You to Stay Calm in SummerJPMorgan Chase: The Financial Fortress Built for Today's InvestorBy Jeffrey Neal Johnson | June 23, 2025View JPMorgan Chase: The Financial Fortress Built for Today's InvestorRCM, EVH, FC, JP, and PHIL Company DescriptionsEvolent Health NYSE:EVH$11.79 +0.06 (+0.51%) As of 07/3/2025 03:30 PM EasternEvolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Franklin Covey NYSE:FC$21.84 -2.33 (-9.62%) Closing price 07/3/2025 03:40 PM EasternExtended Trading$21.84 0.00 (0.00%) As of 07/3/2025 04:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Franklin Covey Co. provides training and consulting services in the areas of execution, sales performance, productivity, customer loyalty, and educational improvement for organizations and individuals worldwide. The company operates through Direct Offices, International Licensees, and Education Practice segments. It also provides a suite of individual-effectiveness and leadership-development training and products. In addition, the company operates Strive platform, a learning deployment platform; Impact platform that helps automate implementation of learning initiatives; All Access Pass, a subscription platform that enables improved deployment of content, services, technology, and metrics to deliver behavioral impact at scale; and Leader in Me, which provides access to digital versions of student leadership guides, leadership lessons, illustrated leadership stories, and other resources. Franklin Covey Co. was incorporated in 1983 and is headquartered in Salt Lake City, Utah.Jupai NYSE:JPJupai Holdings Limited, together with its subsidiaries, provides wealth management products and advisory services to high-net-worth individuals in China. It offers services for fixed income products, private equity and venture capital funds, and public market products, as well as other products, including overseas insurance products and foreign-currency denominated alternative investments. The company also provides asset management services, including management of real estate or related funds and other fund products. In addition, it offers fund management services, as well as advisory and administrative services. As of December 31, 2021, it operated 22 client centers in 22 cities in Mainland China and Hong Kong. The company was formerly known as Jupai Investment Group and changed its name to Jupai Holdings Limited in December 2014. Jupai Holdings Limited was founded in 2010 and is headquartered in Shanghai, China.PHI Group OTCMKTS:PHIL$0.0001 0.00 (-50.00%) As of 07/3/2025 12:37 PM EasternPhilux Global Group Inc. engages in the provision of merger and acquisition advisory, consulting, project financing, and capital market services to clients in North America and Asia. It also produces and sells spirits; and focus on various sub-funds for investment in real estate, renewable energy, infrastructure, agriculture, healthcare, and the international financial center and Asia diamond exchange. The company was formerly known as PHI Group, Inc. and changed its name to Philux Global Group Inc. in August 2022. Philux Global Group Inc. was incorporated in 1982 and is headquartered in Irvine, California.R1 RCM NASDAQ:RCMR1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
